Indiana Hemophilia & Thrombosis Center is a clinical research site located in Indianapolis, Indiana, United States.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Indiana Hemophilia & Thrombosis Center has participated in 14 clinical trials with 1 currently active.
Therapeutic areas: Hemophilia A, Hemophilia B, Factor X Deficiency.
Sponsors: OPKO Health, Inc., Bio Products Laboratory, Skane University Hospital.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Indiana Hemophilia & Thrombosis Center has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Indiana Hemophilia & Thrombosis Center has 14 clinical trials on record, with 1 currently active. Their work covers Hemophilia A, Hemophilia B, Factor X Deficiency.
Yes — Indiana Hemophilia & Thrombosis Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.